WST West Pharmaceutical Services Inc

  1. Stocks
  2. Healthcare
  3. NYSE: WST

Price (delayed)

$284.76

Market cap

$20.66B

P/E Ratio

40.05

Dividend/share

$0.79

EPS

$7.11

Enterprise value

$20.52B

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, ...

Highlights
The stock's price to earnings (P/E) is 19% less than its last 4 quarters average of 48.0 and 18% less than its 5-year quarterly average of 47.7
WST's EPS is down by 7% since the previous quarter but it is up by 2.2% year-on-year
West Pharmaceutical Services's quick ratio has decreased by 44% YoY and by 16% from the previous quarter
The net income has contracted by 8% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.westpharma.com
Peers: BDX ICUI SYK BAX

Key stats

What are the main financial stats of WST
Market
Shares outstanding
72.54M
Market cap
$20.66B
Enterprise value
$20.52B
Valuations
Price to earnings (P/E)
40.05
Price to book (P/B)
8.05
Price to sales (P/S)
7.23
EV/EBIT
32.35
EV/EBITDA
26.3
EV/Sales
7.13
Earnings
Revenue
$2.88B
EBIT
$634.3M
EBITDA
$780.4M
Free cash flow
$357.1M
Per share
EPS
$7.11
Free cash flow per share
$4.89
Book value per share
$35.37
Revenue per share
$39.41
TBVPS
$46.15
Balance sheet
Total assets
$3.49B
Total liabilities
$912.6M
Debt
$310.7M
Equity
$2.58B
Working capital
$849.3M
Liquidity
Debt to equity
0.12
Current ratio
2.34
Quick ratio
1.46
Net debt/EBITDA
-0.17
Margins
EBITDA margin
27.1%
Gross margin
35.7%
Net margin
18.2%
Operating margin
20.4%
Efficiency
Return on assets
14.3%
Return on equity
19.1%
Return on invested capital
25%
Return on capital employed
22.2%
Return on sales
22%
Dividend
Dividend yield
0.28%
DPS
$0.79
Payout ratio
11.1%

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
2.74%
1 week
-10.43%
1 month
-12.02%
1 year
-24.95%
YTD
-19.13%
QTD
-13.55%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.88B
Gross profit
$1.03B
Operating income
$587.2M
Net income
$524.9M
Gross margin
35.7%
Net margin
18.2%
The operating margin has declined by 11% year-on-year and by 7% since the previous quarter
WST's operating income is down by 10% YoY and by 9% from the previous quarter
The net income has contracted by 8% from the previous quarter
WST's net margin is down by 6% since the previous quarter

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
WST P/E details
P/E
40.05
P/B
8.05
P/S
7.23
EV/EBIT
32.35
EV/EBITDA
26.3
EV/Sales
7.13
The stock's price to earnings (P/E) is 19% less than its last 4 quarters average of 48.0 and 18% less than its 5-year quarterly average of 47.7
WST's EPS is down by 7% since the previous quarter but it is up by 2.2% year-on-year
The price to book (P/B) is 23% lower than the 5-year quarterly average of 10.2 and 19% lower than the last 4 quarters average of 9.7
WST's equity is down by 6% year-on-year and by 3.9% since the previous quarter
The P/S is 24% below the last 4 quarters average of 9.2 and 20% below the 5-year quarterly average of 8.8

Efficiency

How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is down by 9% since the previous quarter and by 4.2% year-on-year
The company's return on assets fell by 7% QoQ
WST's return on sales is down by 7% since the previous quarter
West Pharmaceutical Services's ROE has decreased by 6% from the previous quarter

Dividends

What is WST's dividend history
DPS
$0.79
Dividend yield
0.28%
Payout ratio
11.1%
Recent dividends

Financial health

How did West Pharmaceutical Services financials performed over time
West Pharmaceutical Services's quick ratio has decreased by 44% YoY and by 16% from the previous quarter
West Pharmaceutical Services's current ratio has decreased by 36% YoY and by 10% QoQ
WST's debt is 88% smaller than its equity
The debt to equity has grown by 9% from the previous quarter and by 9% YoY
WST's equity is down by 6% year-on-year and by 3.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.